ALPHA TRIBE

Sun Pharma Advanced Research Company LimitedUpdates, 24-02-2026: General Updates

24-02-2026 | 03:00 pm

SPARC clarified its valuation report following an NSE query, explaining why income-based valuation (DCF) is unsuitable. This is due to its R&D business, consistent losses, and lack of predictable revenue streams, making future projections difficult.

No comments yet. Be the first to comment!

All announcements from Sun Pharma Advanced Research Company Limited